Nonetheless, even if the administration of SGLT2 inhibitor was unable to counteract the onset of hypertension caused by the administration of Ang II, but caused only a slight, but not significant, reduction of blood pressure levels as compared to Ang II-treated group (Table 1), it was nonetheless effective in preventing the development of myocardial damage. This evidence concerns the gene AGT and Hypertension.